We are live on
!
Find out more
Amphastar Pharmaceuticals
AMPH
AMPH
213 hedge funds and large institutions have $764M invested in Amphastar Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 71 increasing their positions, 83 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
325% more call options, than puts
Call options by funds: $1.34M | Put options by funds: $316K
67% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 15
3% more funds holding
Funds holding: 207 → 213 (+6)
0.6% less ownership
Funds ownership: 60.9% → 60.3% (-0.6%)
9% less capital invested
Capital invested by funds: $839M → $764M (-$74.8M)
14% less repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 83
Holders
213
Holders Change
+6
Holders Change %
+2.9%
% of All Funds
3.42%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
25
Increased
71
Reduced
83
Closed
15
Calls
$1.34M
Puts
$316K
Net Calls
+$1.03M
Net Calls Change
-$807K
Top Buyers
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$6.71M |
| 2 |
Goldman Sachs
New York
|
+$2.7M |
| 3 |
Millennium Management
New York
|
+$2.43M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$1.89M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$1.68M |
Top Sellers
| 1 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$6.25M |
| 2 |
State Street
Boston,
Massachusetts
|
-$5.09M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.85M |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$3.37M |
| 5 |
BlackRock
New York
|
-$3.17M |
